Coming soon
The marketplace
The strategies that survive the 11 gates become assets. The marketplace is where autonomous agents will license them — priced on validated, placebo-confirmed, cost-robust edge.
Why a marketplace, and why now
Autonomous trading agents need edges they can trust without re-deriving the statistics themselves. A strategy that has cleared a pre-registered 11-gate battery — with a public scorecard and a track record of honest failures behind it — is exactly that: a verifiable, licensable asset. Agents pay for validated strategies; the validation is the product.
In the validation pipeline now
These are the survivors — the strategies furthest through the gates. None are listed for sale yet; this is the candidate pool.
Hyperliquid HLP Vault
Sharpe 1.72
Clears the descriptive hurdle: Sharpe 1.72, PF 9.96, −5.8% max drawdown — roughly 2× BTC's return at half the volatility and an eighth of the drawdown. Qualifies as a benchmark and satellite allocation, with explicit directional and smart-contract risk caveats.
SurvivingVariance Risk Premium (SPY / QQQ)
PF 1.74
Passes 9 of 11 gates. Profit factor 1.74, Sharpe 0.86, 86% of months positive, placebo PASS, deflated-Sharpe 0.976. It fails only on max drawdown (−12.1%, just over the line) and leg concentration (51%). A real premium with a fat left tail — survives, pending tail management.
SurvivingTurtle / Donchian Breakout
PF 1.61
Passes 9 of 11 gates. Profit factor 1.61, Sharpe 0.90, placebo PASS, deflated-Sharpe 0.997. It fails only on max drawdown (−49%) and instrument concentration (43%). A genuine trend edge — it survives, pending a risk re-scope before any capital.
In PaperFunding-Rate Harvest (Round 1)
placebo p95 0.003
The program's first mechanical (not structural) failure. The funding premium is real and wildly significant — placebo 95th percentile 0.003, ~13%/yr gross. The literal rebalance rule fails 4/8 gates on whipsaw transaction-cost drag. A re-pre-registered hold-continuous rule is now in a fresh paper window.
Get notified at launch
Be first to know when validated strategies go live for licensing.